RE104 Safety and Efficacy Study in Postpartum Depression
Public ClinicalTrials.gov record NCT06342310. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Parallel-Group Dose-Controlled Study Evaluating the Safety and Efficacy of RE104 for Injection in the Treatment of Patients With Postpartum Depression (PPD)
Study identification
- NCT ID
- NCT06342310
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Reunion Neuroscience Inc
- Industry
- Enrollment
- 84 participants
Conditions and interventions
Conditions
Interventions
- RE104 for Injection Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 45 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 13, 2024
- Primary completion
- May 21, 2025
- Completion
- Jun 15, 2025
- Last update posted
- May 13, 2026
2024 – 2025
United States locations
- U.S. sites
- 38
- U.S. states
- 22
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Reunion Investigational Site | Birmingham | Alabama | 35209 | — |
| Reunion Investigational Site | Tucson | Arizona | 85724 | — |
| Reunion Investigational Site | Santa Monica | California | 90404 | — |
| Reunion Investigational Site | Boulder | Colorado | 80045 | — |
| Reunion Investigational Site | Denver | Colorado | 80209 | — |
| Reunion Investigational Site | Lauderhill | Florida | 33319 | — |
| Reunion Investigational Site | Tampa | Florida | 33613 | — |
| Reunion Investigational Site | Atlanta | Georgia | 30329 | — |
| Reunion Investigational Site | Atlanta | Georgia | 30331 | — |
| Reunion Investigational Site | Decatur | Georgia | 30030 | — |
| Reunion Investigational Site | Marietta | Georgia | 30060 | — |
| Reunion Investigational Site | Savannah | Georgia | 31405 | — |
| Reunion Investigational Site | Honolulu | Hawaii | 96817 | — |
| Reunion Investigational Site | Kansas City | Kansas | 66160 | — |
| Reunion Investigational Site | Shreveport | Louisiana | 71106 | — |
| Reunion Investigational Site | Baltimore | Maryland | 21205 | — |
| Reunion Investigational Site | Rockville | Maryland | 20850 | — |
| Reunion Investigational Site | Springfield | Massachusetts | 01103 | — |
| Reunion Investigational Site | Novi | Michigan | 48377 | — |
| Reunion Investigational Site | Albuquerque | New Mexico | 87131 | — |
| Reunion Investigational Site | Buffalo | New York | 14202 | — |
| Reunion Investigational Site | New York | New York | 10016 | — |
| Reunion Investigational Site | New York | New York | 10026 | — |
| Reunion Investigational Site | Chapel Hill | North Carolina | 27599 | — |
| Reunion Investigational Site | Monroe | North Carolina | 28112 | — |
| Reunion Investigational Site | Cleveland | Ohio | 44113 | — |
| Reunion Investigational Site | Columbus | Ohio | 43210 | — |
| Reunion Investigational Site | West Chester | Pennsylvania | 19380 | — |
| Reunion Investigational Site | Austin | Texas | 78712 | — |
| Reunion Investigational Site | Austin | Texas | 78737 | — |
| Reunion Investigational Site | Austin | Texas | 78759 | — |
| Reunion Investigational Site | Plano | Texas | 75093 | — |
| Reunion Investigational Site | San Antonio | Texas | 78229 | — |
| Reunion Investigational Site | Draper | Utah | 84020 | — |
| Reunion Investigational Site | Salt Lake City | Utah | 84108 | — |
| Reunion Investigational Site | Charlottesville | Virginia | 22903 | — |
| Reunion Investigational Site | Seattle | Washington | 98105 | — |
| Reunion Investigational Site | Madison | Wisconsin | 53719 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06342310, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 13, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06342310 live on ClinicalTrials.gov.